Development sources

Evidence sources

The documents below contain clinical guideline recommendations or other recommendations that were used by the TEG to develop the quality standard statements and measures.

Anxiety. NICE clinical guideline 113 (2011; NHS Evidence accredited).

Depression with a chronic physical health problem. NICE clinical guideline 91 (2009; NHS Evidence accredited)

Depression in adults. NICE clinical guideline 90 (2009; NHS Evidence accredited).

Needle and syringe programmes. NICE public health guidance 18 (2009; NHS Evidence accredited). This has been updated and replaced by Needle and syringe programmes. NICE public health guidance 52 (2014; NHS Evidence accredited).

Drug misuse: opioid detoxification. NICE clinical guideline 52 (2007; NHS Evidence accredited).

Drug misuse: psychosocial interventions. NICE clinical guideline 51 (2007; NHS Evidence accredited).

Department of Health (England) and the devolved administrations (2007) Drug misuse and dependence: UK guidelines on clinical management.

Policy context

It is important that the quality standard is considered alongside current policy documents, including:

National Treatment Agency for Substance Misuse (2011). Recovery-orientated drug treatment interim report.

HM Government (2010). Drug strategy 2010: reducing demand, restricting supply, building recovery: supporting people to live a drug-free life.

National Treatment Agency for Substance Misuse (2010). Annual statistical reports from National Drug Treatment Monitoring System.

Definitions and data sources for the quality measures

References included in the definitions and data sources sections:

National Treatment Agency for Substance Misuse (accessed March 2011). Skills and workforce: toolkits and resources.

National Treatment Agency for Substance Misuse (2011). National and regional estimates of the prevalence of opiate and/or crack cocaine use 2009–10

National Treatment Agency for Substance Misuse (2012). National Drug Treatment Monitoring System core dataset J

NICE (2007). NICE audit support for misuse of drugs and other substances (NICE public health guidance 4 and clinical guidelines 51 and 52).